Skin cancer is one of the most common cancers in the UK, with non-melanoma cases exceeding 150,000 annually and melanoma cases rising. 

1 in 36 men and 1 in 47 women will be diagnosed with skin cancer in their lifetime

A new NHS treatment, semaglutide (Wegovy), will be available this summer for people in Greenwich with cardiovascular disease who are overweight (BMI 27+) and have had a heart attack, stroke, or serious circulation problems, offering a proven 20% reduction in risk of future heart attacks and strokes when combined with lifestyle changes and existing medications. 

Sharing your healthcare experience can make a big difference to your local services. Take a moment to give your feedback and help make care better. 

Join us for our Annual General Meeting and help us shape our future plans.